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Background: The use of antibiotics is the single most important driver in antibiotic resistance. Nevertheless,
antibiotic overuse remains common. Decline in antibiotic prescribing in the United States coincided with the
launch of national educational campaigns in the 1990s and other interventions, including the introduction of
routine infant immunizations with the pneumococcal conjugate vaccine (PCV-7); however, it is unknown if these
trends have been sustained through recent measurements.
Methods: We performed an analysis of nationally representative data from the Medical Expenditure Panel Surveys
from 2000 to 2010. Trends in population-based prescribing were examined for overall antibiotics, broad-spectrum
antibiotics, antibiotics for acute respiratory tract infections (ARTIs) and antibiotics prescribed during ARTI visits. Rates
were reported for three age groups: children and adolescents (<18 years), adults (18 to 64 years), and older adults
(≥65 years).
Results: An estimated 1.4 billion antibiotics were dispensed over the study period. Overall antibiotic prescribing
decreased 18% (risk ratio (RR) 0.82, 95% confidence interval (95% CI) 0.72 to 0.94) among children and adolescents,
remained unchanged for adults, and increased 30% (1.30, 1.14 to 1.49) among older adults. Rates of broad-
spectrum antibiotic prescriptions doubled from 2000 to 2010 (2.11, 1.81 to 2.47). Proportions of broad-spectrum
antibiotic prescribing increased across all age groups: 79% (1.79, 1.52 to 2.11) for children and adolescents, 143%
(2.43, 2.07 to 2.86) for adults and 68% (1.68, 1.45 to 1.94) for older adults. ARTI antibiotic prescribing decreased 57%
(0.43, 0.35 to 0.52) among children and adolescents and 38% (0.62, 0.48 to 0.80) among adults; however, it remained
unchanged among older adults. While the number of ARTI visits declined by 19%, patients with ARTI visits were
more likely to receive an antibiotic (73% versus 64%; P <0.001) in 2010 than in 2000.
Conclusions: Antibiotic use has decreased among children and adolescents, but has increased for older adults.
Broad-spectrum antibiotic prescribing continues to be on the rise. Public policy initiatives to promote the judicious
use of antibiotics should continue and programs targeting older adults should be developed.
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Antibiotic resistance has been called one of the world’s
most pressing public health problems [1]. Infections due
to antibiotic-resistant organisms are associated with
loss of productivity, poorer health outcomes and grea-
ter health care costs [2-4]. Antibiotic resistance is* Correspondence: freic@uthscsa.edu
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reproduction in any medium, provided the orestimated to cost $60 billion annually in the United
States (US) [5].
Antibiotics are one of the most commonly prescribed
drugs in the US. The use of antibiotics is the main dri-
ver in creating selective pressure for the emergence of
antibiotic-resistant bacteria. Nevertheless, antibiotic over-
use remains common [6-8]. Despite a high probability
of viral etiology, acute respiratory tract infections (ARTIs),
such as bronchitis, pharyngitis and sinusitis, account
for 75% of all antibiotics prescribed by office-based
providers [9-11]. Prior studies have demonstrated that. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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necessary [12-15].
To target this growing concern, in 1995, the US Cen-
ters for Disease Control and Prevention (CDC) launched
its ‘Get Smart: Know When Antibiotics Work’ campaign,
a broad-scale, national educational campaign to promote
appropriate use of antibiotics, particularly for ARTIs
[16]. Subsequently, various reports in the late 1990s and
early 2000s demonstrated a decline in antibiotic use
[17-19]. Other interventions not directly targeting anti-
biotic use may have also reduced antibiotic utilization.
For example, after the initiation of the routine infant
pneumococcal vaccination with the pneumococcal con-
jugate vaccine (PCV-7) in 2000, reports have shown that
the rates of invasive disease due to penicillin-resistant
Streptococcus pneumoniae have declined. However, it is
unknown if these national antibiotic prescribing patterns
have continued in more recent years.
The purpose of this study was to describe national trends
in outpatient antibiotic prescribing, broad-spectrum anti-
biotic prescribing, and antibiotic prescribing for ARTIs
from 2000 to 2010. We also aimed to examine national




This study utilized data from the Medical Expenditure
Panel Survey (MEPS) administered by the Agency for
Healthcare Research and Quality [20]. The MEPS are a
national set of surveys of individuals, families and their
medical providers and employers. It provides national
estimates of health care use, expenditures, payment sour-
ces and health insurance coverage for the US civilian,
non-institutionalized population, annually. The MEPS are
conducted using an overlapping panel design, in which a
new panel of approximately 35,000 respondents is added
each year. Data are collected in five rounds of interviews
over two and a half calendar years. Each of the five inter-
views includes all health care utilization events for a spe-
cific time, and these time periods cumulatively covered a
two-year period. At the time of the draft of this manu-
script, MEPS survey data were complete to year 2010.
The MEPS include three main components: the House-
hold Component (HC), the Medical Provider Component
(MPC) and the Insurance Component. The MEPS HC
contains information on families and individuals regarding
their demographics, health conditions, health status and
expenditures. The MEPS MPC includes information pro-
vided by a sample of medical providers that supplements
the information acquired during completion of the house-
hold interviews. Information in the MEPS MPC includes
dates of visits, diagnosis and procedure codes, charges and
payments. The Pharmacy Component, a sub-componentof the MEPS HC, contains the ‘Prescribed Medicines’
files. Medications are obtained from survey respon-
dents; additional details are imputed from data that
are obtained from the patients’ pharmacies (for example,
National Drug Codes, medication name, date filled and
payment sources). Each record in the file represents a
unique prescribed medicine event and purchase by the
household respondent or member. Expenditures, medical
conditions and household characteristics related to the
prescribed medicine are also provided.
Study design and definitions
We performed a retrospective analysis of outpatient
antibiotic prescribing from 2000 to 2010. In the MEPS,
survey respondents are asked to report health conditions
which are then coded by professional coders using the
International Classification of Diseases, 9th Revision, Cli-
nical Modification (ICD-9-CM) diagnoses codes. These
conditions are recorded at the person-level in conjunc-
tion with medical events, including outpatient visits and
antibiotic purchases. We assessed antibiotic prescribing
trends in overall antibiotic use, broad-spectrum antibi-
otics, outpatient visits, and for common ARTIs that infre-
quently necessitate an antibiotic: acute nasopharyngitis
and upper respiratory tract infection (ICD-9-CM diagno-
sis codes 460 and 465), bronchitis (466 and 490), influenza
(480, 487 and 488), pharyngitis (034, 462 and 463), and si-
nusitis (461 and 473) [18,21,22]. Outpatient visits included
visits with medical providers in office-based settings and
clinics, hospital outpatient departments and phone con-
tacts with office-based medical providers.
Therapeutic drug classes were identified by using the
National Drug Code directory, generic names, and the
Multum Lexicon therapeutic classification database
(Cerner Multum, Inc). ‘Broad-spectrum’ antibiotics were
defined using the National Committee for Quality As-
surance’s (NCQA) ‘Antibiotics of Concern List,’ which
includes azithromycin, clarithromycin, fluoroquinolones,
amoxicillin-clavulanate, and second- and third-generation
cephalosporins [23]. ‘Major antibiotic classes’ included
macrolides, cephalosporins, penicillins and fluoroquino-
lones. Antibiotics for ARTIs were defined as events of
antibiotic purchase linked to ICD-9-CM codes mentioned
above. We excluded any antibiotic that was reported as a
topical route of administration.
Data and statistical analyses
Antibiotic prescriptions were analyzed at the level of a
unique prescribed medicine event and prescription pur-
chase. Prescription rates were defined as the annual num-
ber of antibiotic prescriptions divided by the overall US
civilian non-institutionalized population. Population de-
nominators were derived from the MEPS HC. The MEPS
estimate US populations based on sampled persons in the
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entire year. Beginning in 2001, MEPS transitioned to 2000
census-based population estimates for post-stratification
and ranking; prior to 2001, 1990 census-based estimates
were used. The sample design of the survey includes
stratification, clustering, multiple stages of selection and
disproportionate sampling. Furthermore, the MEPS use
sampling weights to reflect adjustments for survey nonre-
sponse and adjustments to population control totals from
the Current Population Survey [20]. Next, we determined
if changes in antibiotic use were uniform across three age
groups: children and adolescents (<18 years), adults (18 to
64 years), and older adults (≥65 years). To account for the
aging population, groups were further stratified into a
total of six subgroups: <5 years, 5 to 17 years, 18 to
49 years, 50 to 64 years, 65 to 79 years, and ≥80 years.
We conducted analyses evaluating trends in both
ARTI visits and visit-based prescribing. ARTI outpatient
visit rates were defined as the annual number of ARTI
outpatient visits divided by the corresponding popula-
tion estimate. Rates in the first study year (2000) were
compared with the final study year (2010) and reported
per 1,000 persons per year. Risk ratios and 95% confi-
dence intervals (95% CIs) were calculated.
ARTI visit-based prescribing was determined as de-
scribed in the study design and definitions. The only dif-
ference was that the data were limited to antibiotic events
that occurred during an ARTI visit. Proportions were esti-
mated accounting for the survey design and tested using
the design-based F test. All analyses were adjusted to ac-
count for the MEPS complex study design using weights,
clustering and stratification to derive national estimates.
SPSS 20.0® (IBM Corp, Armonk, NY, USA) was used for




































Figure 1 Antibiotic prescribing in the United States, 2000 to 2010. Da
95% confidence intervals. Rates are per 1,000 population.Results
Antibiotic prescription rates
During the study period (2000 to 2010), an estimated 1.4
billion outpatient antibiotics were dispensed in the US.
The annual number of outpatient antibiotic prescrip-
tions purchased ranged from 106 million in 2000 to 134
million in 2003.
Annual antibiotic prescription rates are shown in
Figure 1. Antibiotic prescription rates remained rela-
tively stable over the study period from 382 (95% CI
360 to 404) per 1,000 persons in 2000 to 384 (365 to
403) per 1,000 persons in 2010. Age-based antibiotic
prescribing rates are shown in Figure 2. Among chil-
dren and adolescents, the annual rate of antibiotic
prescriptions remained stable from 2000 to 2003; sub-
sequently, rates declined by 25% from 2003 to 2010.
For adults, antibiotic prescribing peaked in 2003 and
then remained stable until 2010. In contrast, rates for
older adults increased 30% from 2000 to 2010.
Table 1 provides a comparison of antibiotic prescribing
between 2000 and 2010. Prescription rates in children
and adolescents decreased 18% from 2000 to 2010 (risk
ratio (RR) 0.82, 95% CI 0.72 to 0.94), mainly driven by
children <5 years of age (0.72, 0.65 to 0.81). Among
adults (18 to 64 years of age), rates were similar in 2000
and 2010 (1.08, 0.93 to 1.26). In contrast, rates increased
significantly for older adults (>65 years of age) from
2000 to 2010 (1.30, 1.14 to 1.49). The most substantial
increase was seen among those ≥80 years old, where
antibiotic prescription rates doubled from 2000 to 2010
(1.96, 1.69 to 2.28).
Broad-spectrum antibiotic prescription rates
Table 1 compares broad-spectrum antibiotic prescrip-
tion rates in 2000 versus 2010. Rates of broad-spectrum2005 2006 2007 2008 2009 2010
Year



































Children and Adolescents Adults Older Adults
Figure 2 Age-based antibiotic prescribing in the United States, 2000 to 2010. Data are from the Medical Expenditure Panel Surveys. Error
bars indicate 95% confidence intervals. Rates are per 1,000 population.
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(2.11, 1.81 to 2.47). Among children and adolescents,
broad-spectrum antibiotic prescriptions increased 49%
in those younger than 5 years of age (1.49, 1.28 to 1.74)
and doubled among those 5 to 17 years of age (2.09,
1.76 to 2.49). The adult population experienced the
greatest increase in broad-spectrum antibiotic prescrib-
ing (2.43, 2.18 to 3.04), including a 2.5-fold increase
among those 18 to 49 years of age (2.57, 2.18 to 3.04)
and a two-fold increase in those 50 to 64 years of age
(2.11, 1.80 to 2.46). Among older adults, broad-spectrum
antibiotic prescribing rates increased 68% from 2000 to
2010 (1.68, 1.45 to 1.94).Antibiotic prescription rates for ARTIs
Table 1 also depicts antibiotic prescription rates for
ARTIs. The US population experienced a significant de-
crease in ARTI antibiotic prescriptions from 2000 to
2010 (0.58, 0.46 to 0.74); however, this decrease occurred
only among groups younger than 50 years of age: 49%
decrease among children ≤4 years of age (0.51, 0.41 to
0.63), 60% decrease among those 5 to 17 years of age
(0.40, 0.33 to 0.48), and 43% decrease among those 18 to
49 years of age (0.57, 0.44 to 0.73). In contrast, there
were no significant changes among groups ≥50 years of
age.Broad-spectrum antibiotic prescription rates for ARTIs
Broad-spectrum antibiotic prescriptions for ARTIs in 2000
versus 2010 are compared in Table 2. In the US population,
broad-spectrum antibiotic prescriptions more than dou-
bled from 2000 to 2010 (2.34, 2.03 to 2.68). This increase
was observed for all age groups, including children andadolescents (1.81, 1.56 to 2.09), adults (2.77, 2.42 to 3.17),
and older adults (2.25, 2.02 to 2.52).
Prescription rates for major antibiotic classes
Penicillin prescribing decreased for children and adoles-
cents (0.80, 0.69 to 0.92), adults (0.83, 0.78 to 0.94) and
older adults (0.80, 0.66 to 0.98). Cephalosporin prescrib-
ing remained stable for children and adolescents (0.90,
0.71 to 1.15), but decreased for adults (0.73, 0.56 to
0.94) and older adults (0.78, 0.61 to 0.99). In contrast,
macrolide prescribing significantly increased for all age
groups: children and adolescents (1.77, 1.43 to 2.17),
adults (1.33, 1.12 to 1.57) and older adults (1.40, 1.16 to
1.69). Finally, fluoroquinolone prescribing remained stable
in adults (0.99, 0.76 to 1.30) and older adults (0.87, 0.72 to
1.05). There were too few events for fluoroquinolones to
estimate use among children and adolescents.
ARTI visits
From 2000 to 2010, the survey estimated 3.1 billion office-
based provider visits and hospital outpatient provider
visits. The rate of outpatient visits did not change signifi-
cantly from 2000 to 2010 for any of the age groups. In
2000, ARTI visits accounted for 28% of all outpatient
visits; in 2010, ARTI visits accounted for approximately
21% of all outpatient visits.
Table 3 compares ARTI visit rates in 2000 and 2010.
The national ARTI visit rates decreased 19% from 2000
to 2010 (0.81, 0.67 to 0.98). This was mainly driven by a
33% decrease among children younger than 5 years of
age (0.67, 0.58 to 0.77) and a 32% decrease among adults
50 to 64 years of age (0.68, 0.54 to 0.85). ARTI visit rates
were not different in older adults between 2000 and
2010 (0.83, 0.65 to 1.07).




2000 2010 Risk ratio (95% CI)
Overall antibiotics
United States population 379 386 1.02 (0.88 to 1.17)
Children and adolescents (<18) 506 416 0.82 (0.72 to 0.94)
0 to 4 776 562 0.72 (0.65 to 0.81)
5 to 17 405 358 0.88 (0.77 to 1.02)
Adults (18 to 64) 328 354 1.08 (0.93 to 1.26)
18 to 49 317 329 1.04 (0.89 to 1.21)
50 to 64 368 410 1.11 (0.97 to 1.28)
Older adults (≥65) 369 480 1.30 (1.14 to 1.49)
65 to 79 405 473 1.17 (1.02 to 1.33)
≥80 254 498 1.96 (1.69 to 2.28)
Broad-spectrum antibioticsb
United States population 223 471 2.11 (1.81 to 2.47)
Children and adolescents (<18) 223 400 1.79 (1.52 to 2.11)
0 to 4 268 400 1.49 (1.28 to 1.74)
5 to 17 191 400 2.09 (1.76 to 2.49)
Adults (18 to 64) 205 499 2.43 (2.07 to 2.86)
18 to 49 194 499 2.57 (2.18 to 3.04)
50 to 64 237 499 2.11 (1.80 to 2.46)
Older adults (≥65) 287 482 1.68 (1.45 to 1.94)
65 to 79 293 489 1.67 (1.44 to 1.93)
≥80 260 466 1.79 (1.54 to 2.09)
Antibiotics for ARTIsc
United States population 175 102 0.58 (0.46 to 0.74)
Children and adolescents (<18) 326 139 0.43 (0.35 to 0.52)
0 to 4 268 138 0.51 (0.41 to 0.63)
5 to 17 352 139 0.40 (0.33 to 0.48)
Adults (18 to 64) 151 94 0.62 (0.48 to 0.80)
18 to 49 171 97 0.57 (0.44 to 0.73)
50 to 64 104 87 0.83 (0.63 to 1.11)
Older adults (≥65) 74 69 0.94 (0.67 to 1.30)
65 to 79 79 80 1.01 (0.74 to 1.37)
≥80 58 41 0.72 (0.58 to 1.07)
aMEPS population estimates in 2000: 36,053,864 (0 to 17 years of age);
106,057,609 (0 to 64 years of age); 29,706,554 (>65 years and older). MEPS
population estimates in 2010: 74,834,192 (0 to 17 years of age); 192,582,188
(0 to 64 years of age); 41,157,595 (>65 years and older); bbroad-spectrum
antibiotics are defined per the National Committee for Quality Assurance
which includes azithromycin, clarithromycin, fluoroquinolones, amoxicillin-
clavulanate, and second- and third-generation cephalosporins; cARTIs include
the following ICD-9-CM codes: bronchitis, 466 and 490; pharyngitis, 034, 462
and 463; sinusitis, 461 and 473; acute nasopharyngitis and upper respiratory
tract infection, 460 and 465; and influenza, 480, 487 and 488. ARTIs, acute
respiratory tract infections; MEPS, Medical Expenditure Panel Surveys; 95% CI,
95% confidence interval.
Table 2 Broad-spectrum prescribing for ARTIs, 2000 and
2010
Antibiotic prescription rates (per
1,000 antibiotic prescriptions)a,b
2000 2010 Risk ratio (95% CI)
United States population 289 675 2.34 (2.03 to 2.68)
Children and adolescents (<18) 273 436 1.81 (1.56 to 2.09)
0 to 4 314 466 1.48 (1.28 to 1.71)
5 to 17 237 516 2.18 (1.87 to 2.54)
Adults (18 to 64) 287 796 2.77 (2.42 to 3.17)
18 to 49 274 766 2.80 (2.45 to 3.21)
50 to 64 339 871 2.57 (2.27 to 2.91)
Older adults (≥65) 457 1030 2.25 (2.02 to 2.52)
65 to 79 464 950 2.05 (1.83 to 2.28)
≥80 423 1416 3.35 (3.00 to 3.73)
aBroad-spectrum antibiotics are defined per the National Committee for
Quality Assurance which includes azithromycin, clarithromycin,
fluoroquinolones, amoxicillin-clavulanate, and second- and third-generation
cephalosporins; bARTI visits were outpatient visits with one or more of the
following ICD-9-CM codes: bronchitis, 466 and 490; pharyngitis, 034, 462 and
463; sinusitis, 461 and 473; acute nasopharyngitis and upper respiratory tract
infection, 460 and 465; and influenza, 480, 487 and 488. ARTIs, acute respiratory
tract infections; 95% CI, 95% confidence interval.
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Although ARTI visits decreased over the study period,
the proportion of antibiotic prescriptions associated with
provider visits for ARTIs increased significantly from
2000 to 2010 (64% versus 73%, P <0.0001). Significant
increases were observed in children and adolescents
(68% versus 75%; P = 0.001) and adults (62% versus 74%;
P <0.0001). Rates were similar among older adults (61%
versus 66%; P = 0.3).
Broad-spectrum antibiotic prescriptions during ARTI visits
There was also a substantial increase in broad-spectrum
antibiotic prescribing during ARTI visits (Figure 3). InTable 3 ARTI visits in the United States, 2000 and 2010
Visit rates (per 1,000 persons)a 2000 2010 Risk ratio (95% CI)
United States population 239 193 0.81 (0.67 to 0.98)
Children and adolescents (<18) 359 302 0.84 (0.72 to 0.97)
0 to 4 481 323 0.67 (0.58 to 0.77)
5 to 17 296 292 0.99 (0.84 to 1.16)
Adults (18 to 64) 207 172 0.83 (0.68 to 1.02)
18 to 49 216 198 0.92 (0.76 to 1.11)
50 to 64 185 125 0.68 (0.54 to 0.85)
Older adults (≥65) 137 114 0.83 (0.65 to 1.07)
65 to 79 148 126 0.85 (0.67 to 1.08)
≥80 104 79 0.76 (0.57 to 1.02)
aARTI visits were outpatient visits with one or more of the following ICD-9-CM
codes: bronchitis, 466 and 490; pharyngitis, 034, 462, and 463; sinusitis, 461
and 473; acute nasopharyngitis and upper respiratory tract infection, 460 and
465; and influenza, 480, 487, and 488. ARTI, acute respiratory tract infection;






















Figure 3 Broad-spectrum antibiotic prescribing during acute respiratory tract infection visits in the United States, 2000 to 2010.
*P <0.0001. Acute respiratory tract infection includes acute nasopharyngitis, upper respiratory tract infection, bronchitis, influenza, pharyngitis and
sinusitis. Data are from the Medical Expenditure Panel Surveys. Error bars represent 95% confidence intervals. Rates are per 1,000 population.
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antibiotics prescribed in outpatient ARTI visits. By 2010,
broad-spectrum antibiotics comprised 46% (P <0.001) of
all antibiotics prescribed for ARTIs. This significant in-
crease was consistent across all age groups: children and
adolescents (17% versus 34%, P <0.0001), adults (17%
versus 54%, P <0.0001) and older adults (19% versus
52%, P <0.0001).
Discussion
This study describes antibiotic prescribing in the US
from 2000 to 2010. Overall, antibiotic use has remained
stable; however, there were opposing trends among dif-
ferent age groups. While antibiotic use decreased among
children and adolescents, there was no change among
adults, and older adults experienced an increase.
Earlier studies have documented declining antibiotic pre-
scription rates among children and adolescents [18,21,24].
McCaig et al. demonstrated a 40% decrease in anti-
biotic prescribing from 1989–1990 through 1999–2000
among children <15 years of age. In a subsequent study,
Finkelstein et al. observed a 24% decrease in antibiotic
prescribing from 1996 to 2000 among children within
nine US health plans [25]. Our study demonstrates that
this decline in antibiotic use among children has con-
tinued through to 2010, representing a major success in
the US. These findings likely reflect a combination of
several factors. This includes national, state and local
initiatives aimed at reducing misdiagnoses of ARTIs
and decreasing inappropriate prescribing of antibiotics.
Also, the introduction of routine infant vaccinations
with the PCV-7 in 2000 coincided with reduced inci-
dence of invasive pneumococcal disease and otitis media,
which can decrease antibiotic use [26,27]. In addition,
since 2008, influenza vaccinations became recommendedfor all children six months and older which may have had
a positive effect on the occurrence of ARTIs [28].
Other age groups did not experience this decline. In
the beginning of the study period, children and ado-
lescents had the highest rate of antibiotic prescriptions
compared to adults and older adults. However, older
adults surpassed children and adolescents to attain the
highest antibiotic prescribing rate in 2004; this was sus-
tained through the end of the study period. A prior
study demonstrated that, while overall antibiotic pre-
scriptions remained stable among persons ≥5 years of
age, there was a significant increase in antibiotic use
among persons ≥50 years of age from 1995 to 2006 [24].
Recently, Zhang et al. estimated that the rate of out-
patient antibiotics among Medicare Part D beneficiaries
(>65 years of age) in 2007 to 2009 was 1.10 person/year
[29]; this rate was higher than the antibiotic prescription
rate among those <65 years of age (0.88 person/year)
[30]. Our study validates and expands on these findings
by demonstrating an increase in antibiotic use over the
last decade among US older adults (370/1,000 persons in
2000 to 480/1,000 persons in 2010).
Perhaps the most alarming finding of this study is the
substantial increase of broad-spectrum antibiotic pre-
scribing. Previously, a cross-sectional study identified an
increase in broad-spectrum antibiotic prescribing from
24% to 48% among adults and from 23% to 40% among
children from 1991–1992 to 1998–1999 [22]. Moreover,
a national study demonstrated that azithromycin and
fluoroquinolone use increased nine-fold and five-fold,
respectively, from 1995–1996 to 2005–2006 [21]. Our
study suggests that this upsurge of broad-spectrum anti-
biotic use is at an unprecedented high.
Changes in antibiotic prescribing rates might have re-
sulted from changes in provider prescribing behavior
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Changes in outpatient visit rates for ARTIs might reflect
changes in factors such as public behavior from educa-
tion, insurance status, disease severity, and internet-
based advice and prescribing [24]. Therefore, we con-
ducted analyses evaluating trends in both ARTI visits
and visit-based prescribing. Our study found that ARTI
visit rates have decreased in the last decade; however,
when patients experience an outpatient ARTI visit, they
are more likely to receive an antibiotic. Steinman et al.
previously demonstrated a decline in visit-related antibio-
tic prescribing rates between 1991–1992 and 1998–1999
for various respiratory tract infections [22]. Similarly,
McCaig et al. found decreasing trends in visit-based
ARTI antibiotic prescribing among children and ado-
lescents from 1989 to 2000 [18]. This decrease was sus-
tained in a subsequent study that evaluated antibiotic
use among children ≤5 years of age, from 1995–1996 to
2005–2006 [25]. However, longitudinal evaluation of
these studies suggests that most of the decrease oc-
curred before 2000 [25,31]. When comparing antibiotic
prescribing during ARTI visits, our data indicate a not-
able 9% increase from 2000 to 2010.
Taking into account reduced ARTI visit-rates, these
trends suggest that, although patients may have been less
likely to make a provider visit, clinicians had a higher pro-
pensity to treat these conditions with an antibiotic in
2010. Moreover, when antibiotics were prescribed during
an ARTI visit, broad-spectrum agents were increasingly
being selected. In 2010, broad-spectrum antibiotics com-
prised almost half of all antibiotics prescribed in US out-
patient provider visits. Overall, this translates into nearly
32 million antibiotic prescriptions for respiratory tract in-
fections, comprised largely of broad-spectrum agents.
Finally, our study suggests that older adults experi-
enced a significant increase in antibiotic prescribing and
constituted the greatest proportion of patients receiving
broad-spectrum antibiotics. This highlights the need for
further studies to better understand antibiotic use among
older adults. The older adult population is rapidly growing
compared to other US age groups. As the ‘baby boomer’
generation approaches retirement age, they will comprise
the largest US health care sector. Targeted quality initia-
tives for this population are needed. Currently, the NCQA
has initiated quality improvement measures for antibiotic
prescribing for children and adults; however, no such met-
rics exist for those 65 years of age and older.
This study has limitations. First, the MEPS database
does not provide information related to patient signs
and symptoms, medication allergies, microbial etiology
or severity of the condition; therefore, direct assessment
of appropriate antibiotic prescribing is difficult. Because
we relied on ICD-9-CM codes, diagnoses are subject to
misclassification. Second, we were not able to distinguishbetween first and follow-up visits. The inclusion of follow-
up visits may have resulted in underestimation of visit-
based antibiotic prescriptions. Antibiotic data were based
on antibiotic prescription purchases; thus, actual antibiotic
prescribing might have been underestimated and may not
necessarily reflect actual antibiotic consumption. Third,
while this study was based on national population esti-
mates, wide confidence intervals seen in point estimates
of specific age groups might have been associated with
smaller sample sizes, thereby resulting in possible unstable
estimates of standard error. Fourth, while this study fo-
cused on ARTIs, varying trends for different indications
that might affect total antibiotic use were not directly eval-
uated in this study. Lastly, the MEPS do not include fed-
eral institutions (that is, federal, military and Veterans
Affairs health care facilities), thus our estimates may not
be generalizable to those populations.Conclusions
In conclusion, overall antibiotic use has decreased among
children and adolescents, but has increased among older
adults. Broad-spectrum antibiotic prescribing has in-
creased among all age ranges. ARTI visits have declined;
however, patients who present for ARTI visits are more
likely to receive an antibiotic than in the past. Our study
highlights the persistent problem of antibiotic overuse.
Public policy initiatives to promote the judicious use of
antibiotics should continue and programs targeting older
adults should be developed.
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